| [1] |
XU Runze, HAN Jingjing, LI Wenqian, YANG Jin.
Advances in risk assessment systems from non-clinical to clinical arrhythmia stages
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 423-433.
|
| [2] |
DAI De-zai.
Cardiac arrhythmias, ion channelopathy and new drug discovery
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(9): 961-965.
|
| [3] |
SHEN Lei, WU Yu-lin.
Effect of sodium-calcium exchanger and its inhibitors on arrhythmia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(6): 610-613.
|
| [4] |
HE Sheng-Hu, XU Xia-Hua, LIU Xiao-Dong, CHEN Shu, SUEN Lei, ZHANG Yi.
Comparison of efficacy and safety of oral amiodarone and propafenone in patients with paroxysmal atrial fibrillation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(3): 292-294.
|
| [5] |
.
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2001, 6(4): 320-321.
|
| [6] |
.
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2001, 6(3): 287-288.
|
| [7] |
WANG De-guo, WANG Xin, WANG An-cai, ZHU Hong-jun, SUN Xian-lin.
Effects of Taxol on the expression and distribution of connexin 43 in cultured cardiac myocytes under hypoxia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(9): 975-980.
|
| [8] |
YUAN Ting, SONG Hong-yan, YAN Dong, CHENG Lu-feng, ZOU Zhou, Parhat Kerram.
Electrophysiological study on arrhythmia induced by sulpiride
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(4): 374-380.
|
